Flow Traders U.S. LLC reduced its position in shares of Tema Heart & Health ETF (NASDAQ:HRTS – Free Report) by 67.6% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 18,263 shares of the company’s stock after selling 38,178 shares during the period. Flow Traders U.S. LLC’s holdings in Tema Heart & Health ETF were worth $522,000 at the end of the most recent quarter.
Separately, JPMorgan Chase & Co. acquired a new stake in Tema Heart & Health ETF in the 2nd quarter valued at approximately $63,000.
Tema Heart & Health ETF Stock Down 0.1%
NASDAQ:HRTS opened at $34.61 on Thursday. Tema Heart & Health ETF has a twelve month low of $25.32 and a twelve month high of $36.20. The business has a 50 day moving average price of $33.56 and a two-hundred day moving average price of $30.59. The company has a market cap of $53.65 million, a P/E ratio of 22.06 and a beta of 0.97.
Tema Heart & Health ETF Announces Dividend
Tema Heart & Health ETF Profile
The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive.
Recommended Stories
- Five stocks we like better than Tema Heart & Health ETF
- Technology Stocks Explained: Here’s What to Know About Tech
- Market Momentum: 3 Stocks Poised for Major Breakouts
- Investing in Travel Stocks Benefits
- 3 Reasons Casey’s General Stores Will Continue Trending Higher
- How to buy stock: A step-by-step guide for beginners
- Golden Cross Alert: 3 Stocks With Major Upside Potential
Want to see what other hedge funds are holding HRTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tema Heart & Health ETF (NASDAQ:HRTS – Free Report).
Receive News & Ratings for Tema Heart & Health ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tema Heart & Health ETF and related companies with MarketBeat.com's FREE daily email newsletter.
